Preventing Atopic Diseases During Childhood - Early Exposure Matters
- PMID: 33717110
- PMCID: PMC7946845
- DOI: 10.3389/fimmu.2021.617731
Preventing Atopic Diseases During Childhood - Early Exposure Matters
Abstract
Atopic diseases in childhood are a major burden worldwide and there is still a lack of knowledge about treatable causes. In industrialized countries such as Germany, almost every second child is sensitized to at least one common allergen. Recent studies show that although the predisposition to allergies is inherited, the adaptive immune system of neonates and infants follows a developmental trajectory and whether an allergy actually occurs depends also on timing of allergen exposure including diet as well as environmental factors. New recommendations are far from being rigid of allergen avoidance; it is rather moving toward conditions that stand for more biodiversity. The observation that introduction of peanuts or eggs early in life significantly reduced the development of a later allergy will change our recommendations for the introduction of complementary foods. This is consistent with the hygiene hypothesis that early provocation shapes the developing immune system so that it reacts appropriately. Therefore, promoting the development of tolerance is at the heart of sensible allergy prevention - and this begins with the last trimester of pregnancy. In light of this concept, actual recommendations are discussed.
Keywords: Th2 cells; allergen; allergy prevention; atopic disease; children; early exposure; immune tolerance; regulatory T cells.
Copyright © 2021 Pierau, Arra and Brunner-Weinzierl.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures
References
-
- Actor JK. 7 - Adaptive Immune Response and Hypersensitivity. In: Actor JK, editor. Elsevier’s Integrated Review Immunology and Microbiology (Second Edition). Philadelphia: W.B. Saunders; (2012). p. 53–9.
-
- Durham SR, Emminger W, Kapp A, Colombo G, de Monchy JG, Rak S, et al. . Long-term clinical efficacy in grass pollen–induced rhinoconjunctivitis after treatment with SQ-standardized grass allergy immunotherapy tablet. J Allergy Clin Immunol (2010) 125:131–138.e7. 10.1016/j.jaci.2009.10.035 - DOI - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
